Marek Trneny, MD, from the Charles University, Prague, Czech Republic, discusses highlights from the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2017, held in Vancouver, BC, Canada. The PDX model in particular is important in terms of drug discovery and testing, and better understanding the mechanism of the disease and drug action.
iwNHL 2017 highlights: the PDX model
